Bio-Rad Laboratories Net Total Equity Issued/Repurchased 2010-2025 | BIO.B

Bio-Rad Laboratories net total equity issued/repurchased for the twelve months ending March 31, 2025 was $-0.566B, a 31.15% decline year-over-year.

  • Bio-Rad Laboratories annual net total equity issued/repurchased for 2024 was $-0.184B, a 55.05% decline from 2023.
  • Bio-Rad Laboratories annual net total equity issued/repurchased for 2023 was $-0.41B, a 107.07% increase from 2022.
  • Bio-Rad Laboratories annual net total equity issued/repurchased for 2022 was $-0.198B, a 574.59% increase from 2021.

Bio-Rad Laboratories Net Total Equity Issued/Repurchased 2010-2025 | BIO.B

  • Bio-Rad Laboratories annual net total equity issued/repurchased for 2024 was $-0.184B, a 55.05% decline from 2023.
  • Bio-Rad Laboratories annual net total equity issued/repurchased for 2023 was $-0.41B, a 107.07% increase from 2022.
  • Bio-Rad Laboratories annual net total equity issued/repurchased for 2022 was $-0.198B, a 574.59% increase from 2021.